Inventor · disambiguated record
Amy Heimberger
Also filed as: HEIMBERGER AMY · HEIMBERGER AMY B
4 granted patents·8 pending applications·1 citations·filing 2006–2022
60Inventor score
Top patents by PatentIndex Score
12 records- 0167US11065285B2Biomarkers and combination therapies using oncolytic virus and immunomodulationDNATRIX INC·Filed 2020·Granted Jul 20, 2021·0 cites·14 claims
- 0266US2015118181A1Concurrent Chemotherapy and ImmunotherapySAMPSON JOHN H·Filed 2014·Application pending·0 cites
- 0365US9399662B2Concurrent chemotherapy and immunotherapySAMPSON JOHN H·Filed 2006·Granted Jul 26, 2016·0 cites·2 claims
- 0463US9675633B2miRNA for treating cancer and for use with adoptive immunotherapiesUNIV TEXAS·Filed 2014·Granted Jun 13, 2017·0 cites·33 claims
- 0561US10238698B2Biomarkers and combination therapies using oncolytic virus and immunomodulationDNA TRIX INC·Filed 2013·Granted Mar 26, 2019·1 cites·6 claims
- 0658US2018215789A1Concurrent Chemotherapy and ImmunotherapyUNIV DUKE·Filed 2018·Application pending·0 cites
- 0752US2024226159A9Low intensity ultrasound combination cancer therapiesUNIV TEXAS·Filed 2022·Application pending·0 cites
- 0852US2019269744A1Biomarkers and combination therapies using oncolytic virus and immunomodulationDNATRIX INC·Filed 2019·Application pending·0 cites
- 0948US2017312304A1miRNA FOR TREATING CANCER AND FOR USE WITH ADOPTIVE IMMUNOTHERAPIESUNIV TEXAS·Filed 2017·Application pending·0 cites
- 1045US2010144802A1Small Molecule Inhibitors for Immune ModulationHEIMBERGER AMY B·Filed 2008·Application pending·0 cites
- 1135US2013129675A1Interferon therapies in combination with blockade of stat3 activationPRIEBE WALDEMAR·Filed 2010·Application pending·0 cites
- 1229US2012021941A1Blood test for the detection of cancerHEIMBERGER AMY B·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Amy Heimberger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →